Cargando…
Characteristics of patients with haematological and breast cancer (1996–2009) who died of heart failure‐related causes after cancer therapy
AIMS: To describe the characteristics and time to death of patients with breast or haematological cancer who died of heart failure (HF) after cancer therapy. Patients with an index admission for HF who died of HF‐related causes (IAHF) and those with no index admission for HF who died of HF‐related c...
Autores principales: | Versace, Vincent L., Berry, Narelle M., Chowdhury, Munir H., Ullah, Shahid, McCarthy, Alexandra L., Atherton, John J., Koczwara, Bogda, Roder, David, Clark, Robyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107977/ https://www.ncbi.nlm.nih.gov/pubmed/27867526 http://dx.doi.org/10.1002/ehf2.12099 |
Ejemplares similares
-
Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment
por: Clark, Robyn A., et al.
Publicado: (2017) -
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
por: Clark, Robyn A., et al.
Publicado: (2019) -
The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015)
por: Kuan, Jew Win, et al.
Publicado: (2023) -
Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen
or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
por: Ng, Huah Shin, et al.
Publicado: (2018) -
Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework
por: Dunn, Jeff, et al.
Publicado: (2021)